News
Current position:Product Center > Cell lines > CLDN > CLDN18 > H_CLDN18.2-eGFP CT-26 Cell Line
H_CLDN18.2-eGFP CT-26 Cell Line
Specifications
Cat. NoGM-C09674
ProductH_CLDN18.2-eGFP CT-26 Cell Line
DescriptionH_CLDN18.2-eGFP CT-26 Cell Line is a clonal stable CT-26 cell line that constitutively expresses the human CLDN18.2 gene, constructed using lentiviral technology.
Product Format1 vial of frozen cells
Quantity5E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
TargetHuman_CLDN18.2 & C-eGFP-3×Flag
Gene ID/Uniprot IDNP_001002026.1
Host CellCT-26
Recovery MediumRPMI 1640+10% FBS+1% P.S
Growth mediumRPMI 1640+10% FBS+1% P.S+4 μg/mL Blasticidin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesAdherent
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Data
H_CLDN18.2-eGFP CT-26 Cell Line (Cat. GM-C09674) was determined by flow cytometry using Anti-CLDN18.2 (In house).
Materials
ReagentOrdering Information
RPMI 1640VivaCell/C3010-0500
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
BlasticidinGenomeditech/GM-040404
Anti-CLDN18.2In house/
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+4 μg/mL Blasticidin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Sequence

CLDN18(isoform2) NP_001002026.1
MAVTACQGLGFVVSLIGIAGIIAATCMDQWSTQDLYNNPVTAVFNYQGLWRSCVRESSGFTECRGYFTLLGLPAMLQAVRALMIVGIVLGAIGLLVSIFALKCIRIGSMEDSAKANMTLTSGIMFIVSGLCAIAGVSVFANMLVTNFWMSTANMYTGMGGMVQTVQTRYTFGAALFVGWVAGGLTLIGGVMMCIACRGLAPEETNYKAVSYHASGHSVAYKPGGFKASTGFGSNTKNKKIYDGGARTEDEVQSYPSKHDYV

Related Products
CLDN18
Cynomolgus_CLDN18.2-eGFP CHO-K1 Cell LineH_CLDN18(isoform2)-eGFP 293 Cell LineH_CLDN18.1-eGFP HEK-293 Cell Line
H_CLDN18.2 MC38 Cell LineH_CLDN18.2 MKN45 Cell LineH_CLDN18.2 MKN45 Cell Line(High Expression)
H_CLDN18.2 MKN45 Cell Line(Low Expression)H_CLDN18.2 MKN45 Cell Line(Medium Expression)H_CLDN18.2(isoform2) CHO-K1 Cell Line
Mouse_CLDN18.2-eGFP CHO-K1 Cell LineRat_CLDN18.2-eGFP CHO-K1 Cell LineRhesus_CLDN18.2-eGFP CHO-K1 Cell Line
Anti-CLDN18.2 hIgG1 Antibody(Zolbetuximab)

HER3(ERBB3)
Cynomolgus_ERBB3(HER3) CHO-K1 Cell Line Cynomolgus_ERBB3(HER3) HEK-293 Cell Line H_ERBB3(HER3) CHO-K1 Cell Line
H_ERBB3(HER3) HEK-293 Cell LineH_ERBB3(HER3) MC38 Cell LineMouse_HER3(ERBB3) CHO-K1 Cell Line

Anti-H_ERBB3(HER3) hIgG1 Antibody(Barecetamab)
Human HER3 Protein; His Tag

TROP2(TACSTD2)
Cynomolgus_Trop2 CHO-K1 Cell LineCynomolgus_TROP2 HEK-293 Cell LineH_TROP2 CHO-K1 Cell Line
H_TROP2 CT26 Cell LineH_TROP2 HEK-293 Cell LineH_TROP2 LLC1 Cell Line
H_TROP2 MC38 Cell Line

Anti-H_TROP2 hIgG1 Antibody(Datopotamab)

Human TROP2 Protein; His Tag

GUCY2C(GC-C)
H_GUCY2C CHO-K1 Cell LineH_GUCY2C HEK-293 Cell Line
Anti-H_GUCY2C hIgG1 Antibody(Indusatumab)

CD3
Jurkat CD3-BsAb Reporter Cell LineCynomolgus_CD3 HEK-293 Cell LineCynomolgus_CD3E(Membrane Bound ECD) CHO-K1 Cell Line
H_CD3 CHO-K1 Cell LineH_CD3 HEK-293 Cell LineH_CD3E(Membrane Bound ECD) CHO-K1 Cell Line
Mouse_CD3 HEK-293 Cell Line


Anti-CD3 hIgG1 Antibody(CH2527)
CLDN3
H_CLDN3 HEK-293 Cell Line

CLDN4
H_CLDN4 HEK-293 Cell Line

CLDN6
Cynomolgus_CLDN6 CHO-K1 Cell LineH_CLDN6 CHO-K1 Cell LineH_CLDN6 HEK-293 Cell Line
H_CLDN6 LLC1 Cell LineMouse_CLDN6 CHO-K1 Cell LineRat_CLDN6 CHO-K1 Cell Line
Rhesus_CLDN6 CHO-K1 Cell Line


Anti-CLDN6/9 hIgG1 Antibody
CLDN9
Cynomolgus_CLDN9 CHO-K1 Cell LineH_CLDN9 CHO-K1 Cell LineH_CLDN9-eGFP HEK-293 Cell Line
ADC Related Product
Anti-DXD Mouse IgG1 Antibody (23E21C5)Anti-DXD Mouse IgG1 Antibody (4A5A12)Anti-Dxd Mouse IgG2a Antibody (17D6A4)
Anti-Eribulin Mouse IgG2a Antibody (10F8G4)
Anti-MMAE Mouse IgG2a Antibody (17A1K11)
Anti-MMAE Mouse IgG2a Antibody (8F6A3)Mouse anti Human IgG-MMAE(Dar4)
Human IgG1 Isotype-DXD (Dar8)Human IgG1 Isotype-Eribulin (Dar4)Human IgG1 Isotype-MMAE (Dar4)
Recombinant DT3C Protein


Current Position:Product Center > Cell lines > CLDN > CLDN18 > H_CLDN18.2-eGFP CT-26 Cell Line
classify
H_CLDN18.2-eGFP CT-26 Cell Line
Specifications
Cat. NoGM-C09674
ProductH_CLDN18.2-eGFP CT-26 Cell Line
DescriptionH_CLDN18.2-eGFP CT-26 Cell Line is a clonal stable CT-26 cell line that constitutively expresses the human CLDN18.2 gene, constructed using lentiviral technology.
Product Format1 vial of frozen cells
Quantity5E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
TargetHuman_CLDN18.2 & C-eGFP-3×Flag
Gene ID/Uniprot IDNP_001002026.1
Host CellCT-26
Recovery MediumRPMI 1640+10% FBS+1% P.S
Growth mediumRPMI 1640+10% FBS+1% P.S+4 μg/mL Blasticidin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesAdherent
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Data
H_CLDN18.2-eGFP CT-26 Cell Line (Cat. GM-C09674) was determined by flow cytometry using Anti-CLDN18.2 (In house).
Materials
ReagentOrdering Information
RPMI 1640VivaCell/C3010-0500
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
BlasticidinGenomeditech/GM-040404
Anti-CLDN18.2In house/
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+4 μg/mL Blasticidin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Sequence

CLDN18(isoform2) NP_001002026.1
MAVTACQGLGFVVSLIGIAGIIAATCMDQWSTQDLYNNPVTAVFNYQGLWRSCVRESSGFTECRGYFTLLGLPAMLQAVRALMIVGIVLGAIGLLVSIFALKCIRIGSMEDSAKANMTLTSGIMFIVSGLCAIAGVSVFANMLVTNFWMSTANMYTGMGGMVQTVQTRYTFGAALFVGWVAGGLTLIGGVMMCIACRGLAPEETNYKAVSYHASGHSVAYKPGGFKASTGFGSNTKNKKIYDGGARTEDEVQSYPSKHDYV

Related Products
CLDN18
Cynomolgus_CLDN18.2-eGFP CHO-K1 Cell LineH_CLDN18(isoform2)-eGFP 293 Cell LineH_CLDN18.1-eGFP HEK-293 Cell Line
H_CLDN18.2 MC38 Cell LineH_CLDN18.2 MKN45 Cell LineH_CLDN18.2 MKN45 Cell Line(High Expression)
H_CLDN18.2 MKN45 Cell Line(Low Expression)H_CLDN18.2 MKN45 Cell Line(Medium Expression)H_CLDN18.2(isoform2) CHO-K1 Cell Line
Mouse_CLDN18.2-eGFP CHO-K1 Cell LineRat_CLDN18.2-eGFP CHO-K1 Cell LineRhesus_CLDN18.2-eGFP CHO-K1 Cell Line
Anti-CLDN18.2 hIgG1 Antibody(Zolbetuximab)

HER3(ERBB3)
Cynomolgus_ERBB3(HER3) CHO-K1 Cell Line Cynomolgus_ERBB3(HER3) HEK-293 Cell Line H_ERBB3(HER3) CHO-K1 Cell Line
H_ERBB3(HER3) HEK-293 Cell LineH_ERBB3(HER3) MC38 Cell LineMouse_HER3(ERBB3) CHO-K1 Cell Line

Anti-H_ERBB3(HER3) hIgG1 Antibody(Barecetamab)
Human HER3 Protein; His Tag

TROP2(TACSTD2)
Cynomolgus_Trop2 CHO-K1 Cell LineCynomolgus_TROP2 HEK-293 Cell LineH_TROP2 CHO-K1 Cell Line
H_TROP2 CT26 Cell LineH_TROP2 HEK-293 Cell LineH_TROP2 LLC1 Cell Line
H_TROP2 MC38 Cell Line

Anti-H_TROP2 hIgG1 Antibody(Datopotamab)

Human TROP2 Protein; His Tag

GUCY2C(GC-C)
H_GUCY2C CHO-K1 Cell LineH_GUCY2C HEK-293 Cell Line
Anti-H_GUCY2C hIgG1 Antibody(Indusatumab)

CD3
Jurkat CD3-BsAb Reporter Cell LineCynomolgus_CD3 HEK-293 Cell LineCynomolgus_CD3E(Membrane Bound ECD) CHO-K1 Cell Line
H_CD3 CHO-K1 Cell LineH_CD3 HEK-293 Cell LineH_CD3E(Membrane Bound ECD) CHO-K1 Cell Line
Mouse_CD3 HEK-293 Cell Line


Anti-CD3 hIgG1 Antibody(CH2527)
CLDN3
H_CLDN3 HEK-293 Cell Line

CLDN4
H_CLDN4 HEK-293 Cell Line

CLDN6
Cynomolgus_CLDN6 CHO-K1 Cell LineH_CLDN6 CHO-K1 Cell LineH_CLDN6 HEK-293 Cell Line
H_CLDN6 LLC1 Cell LineMouse_CLDN6 CHO-K1 Cell LineRat_CLDN6 CHO-K1 Cell Line
Rhesus_CLDN6 CHO-K1 Cell Line


Anti-CLDN6/9 hIgG1 Antibody
CLDN9
Cynomolgus_CLDN9 CHO-K1 Cell LineH_CLDN9 CHO-K1 Cell LineH_CLDN9-eGFP HEK-293 Cell Line
ADC Related Product
Anti-DXD Mouse IgG1 Antibody (23E21C5)Anti-DXD Mouse IgG1 Antibody (4A5A12)Anti-Dxd Mouse IgG2a Antibody (17D6A4)
Anti-Eribulin Mouse IgG2a Antibody (10F8G4)
Anti-MMAE Mouse IgG2a Antibody (17A1K11)
Anti-MMAE Mouse IgG2a Antibody (8F6A3)Mouse anti Human IgG-MMAE(Dar4)
Human IgG1 Isotype-DXD (Dar8)Human IgG1 Isotype-Eribulin (Dar4)Human IgG1 Isotype-MMAE (Dar4)
Recombinant DT3C Protein


Tel: 400-627-9288
Message consultation
reset
submit
Service
WhatApp
Phone
Message
Message consultation
reset
submit